
Pharma stocks are presently in the doldrums owing to various factors. However, this is the opportune time to buy a high-quality small-cap Pharma stock which has the credentials to shower multibagger gains, say experts
Prof Sanjay Bakshi & Sanjoy Bhattacharyya, both eminent value investing dons, have loaded up on a small-cap stock on the basis that it has huge scalability, strong return ratios and free cash generation. However, the consistent poor results coupled with rumours of financial impropriety have sparked fear amongst novice investors that the stock may be a ‘house of cards’
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Rakesh Jhunjhunwala
Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala
Recent Comments